Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00690703 | Radiofrequency Ablation of Pulmonary Tumors Response Evaluation | PHASE2 | COMPLETED | 106 | — | — | Jul 1, 2001 | Dec 1, 2007 | Jun 5, 2008 | 7 | United States, Australia +3 |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Treatment |
| Name | Type | Description |
|---|---|---|
| RF ablation (Rita Medical Systems Model 1500x) | DEVICE | computed tomography-guided RF ablation with an expandable electrode needle |
Inclusion Criteria: 1. adult (\> 18 years) male or female patient 2. patient has biopsy-proven NSCLC or lung metastasis 3. patient has been rejected for surgery and has been considered unfit for radiation therapy or chemotherapy 4. patient has as many as 3 tumors per lung, each 3.5 cm or smaller in...